ABOT - Abbott Laboratories (Pak) Ltd. PSX Stock Snapshot | Fundamentals ,Technicals and Market data (PE Book Value Trading Signals EPS ROE ROA)

BML 6.13 / 91.23M 0.18 |

HUMNL 14.23 / 47.41M -0.14 |

TPLP 12.46 / 45.39M 1.13 |

FNEL 23.91 / 38.62M 1.60 |

FFL 20.64 / 35.65M 1.37 |

BOP 35.69 / 35.07M 0.73 |

BNL 13.57 / 27.20M -0.65 |

KEL 5.73 / 23.24M -0.01 |

MLCF 122.02 / 22.23M 11.09 |

HASCOL 14.50 / 20.06M 0.57 |

PIAHCLA 48.36 / 19.56M 0.73 |

FCCL 57.91 / 18.32M 2.01 |

PTC 47.70 / 17.54M -0.30 |

ASL 14.18 / 14.18M 0.32 |

WTL 1.82 / 13.87M 0.01 |

NPL 51.11 / 12.51M 4.65 |

PAEL 55.89 / 11.04M 0.14 |

BECO 6.92 / 10.42M 0.06 |

NCPL 41.38 / 9.40M 3.76 |

PACE 20.46 / 8.98M 0.41 |

AGHA 8.50 / 8.17M 0.24 |

SPWL 12.00 / 8.07M 0.64 |

NML 162.93 / 7.67M 8.56 |

DCL 13.55 / 7.60M 0.61 |

DGKC 250.30 / 7.49M 7.14 |

PIAA 22.17 / 7.47M 1.52 |

KOSM 7.20 / 6.90M -0.02 |

QUICE 12.77 / 6.88M 1.16 |

UNITY 22.60 / 6.72M 0.55 |

EPCL 34.20 / 6.27M -0.17 |

MUGHAL 93.20 / 6.23M 2.34 |

KTML 65.50 / 6.12M 3.58 |

PREMA 42.15 / 6.07M 2.75 |

CNERGY 7.87 / 6.04M -0.03 |

GCWL 20.66 / 5.63M 0.19 |

TREET 32.25 / 5.52M 0.41 |

GGL 27.53 / 5.32M 0.90 |

LOTCHEM 29.30 / 5.15M 0.20 |

TBL 12.67 / 4.98M 0.21 |

TELE 11.78 / 4.98M 0.00 |

POWER 19.03 / 4.94M 0.43 |

WAVES 13.97 / 4.88M 0.23 |

CWSM 53.37 / 4.69M 1.45 |

KOHC 109.01 / 4.56M 3.94 |

TPL 9.79 / 4.24M 1.00 |

PRL 37.95 / 4.18M -0.33 |

TPLT 8.56 / 3.95M 1.00 |

GHGL 37.44 / 3.90M 2.51 |

SNBL 25.78 / 3.78M 0.32 |

BIPL 35.25 / 3.72M 2.01 |

Standard Capital Committed to Intelligent Investing

Snapshot / ABOT - Abbott Laboratories (Pak) Ltd.

Snapshot Menu

ABOT - Abbott Laboratories (Pak) Ltd.

PHARMACEUTICALS

Rs. 1,024.00

-1.95 (-0.19%)

Volume:

7,871

Market Cap:

100.25 bn

Avg Volume (12M):

28,838

Day`s Range

Rs. 1,023.01

Rs. 1,026.00

1 Month Range

Rs. 1,025.64

Rs. 1,092.80

6 Month Range

Rs. 929.22

Rs. 1,299.46

52 Week`s Range

Rs. 790.00

Rs. 1,310.00

Performance

1 Month

3 Month

6 Month

1 Year

-6.68 %

-13.35 %

2.89 %

-9.29 %

Paid Up Capital:

979.00 mn

Authorized Capital:

2,000.00 mn

Total No. Shares:

97.90 mn

Free Float:

21.14 mn

Beta:

0.89

Facevalue:

10.00

Free Float %:

21.60 %

Year End:

December

Market Cap:

100.25 bn

Business Description

Abbott Laboratories (Pakistan) Limited is a public limited company incorporated in Pakistan on July 02, 1948. The Company is principally engaged in the manufacture, import and marketing of branded generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital and consumer products.

Recent Announcements

Ann Type	Ann Date	Description	Image	PDF
Financial Result	29-Oct-2025	Financial Results for the Quarter Ended September 30, 2025	View	PDF
Board Meetings	22-Oct-2025	Board Meeting at 10-Dec-2025	View	PDF
Financial Result	28-Aug-2025	Financial Results for the Quarter Ended June 30, 2025	View	PDF
Board Meetings	20-Aug-2025	Board Meeting at 10-Dec-2025	View	PDF
Financial Result	28-Apr-2025	Financial Results for the Quarter Ended March 31, 2025	View	PDF

Earnings

Latest EPS Upto 2025 3Q

EPS Last Quarter 2025 3Q

Last Annual EPS Upto 2024 4Q

Price To Earning P/E Upto 2024 4Q

Exp Price To Earning P/E Upto 2025 3Q

Exp Earning Gowth Upto 2025 3Q

Price Earning Growth Upto 2025 3Q

Rs. 54.81

Rs. 18.62

Rs. 53.46

19.19 x

14.04 x

36.70 %

0.38 x

Important Ratios

Gross Margin Upto 2024 4Q

Sales Growth (YoY) 2023 to 2024

Sales Growth (QoQ) 2Q 2025 to 3Q 2025

Enterprise Value Per Share Upto 2025 3Q

Book Value Per Share Upto 2025 3Q

Debt to Equity Ratio Upto 2024 4Q

xPrice Date Dividend: 100%

28.95 %

22.90%

3.98%

Rs. 958.94

Rs. 289.63

57.07 %

14-Apr-2025

Equity Ratios

Book Value Upto 2025 3Q

Exp Book Value Upto 2025 3Q

Book Value Growth Upto 2024 4Q

Exp Book Value Growth Upto 2025 3Q

Price To Book Value Upto 2025 3Q

Exp Price To Book Value Upto 2025 3Q

Return On Equity Upto 2024 4Q

Exp Return On Equity Upto 2025 3Q

Retention Ratio Upto 2024 4Q

Exp Retention Ratio Upto 2025 3Q

Equity To Assets Ratio Upto 2024 4Q

Return On Assets Upto 2024 4Q

Return On Cap Employed Upto 2024 4Q

Rs. 289.63

Rs. 349.04

30.09 %

20.51 %

3.54 x

2.94 x

22.06 %

20.94 %

81.30 %

81.29 %

63.01 %

13.90 %

35.65 %

Dividends

Latest Dividend Upto 2024 4Q

Dividend Last Quarter 2024 4Q

Last Annual Dividend Upto 2024 4Q

Dividend Yield Upto 2024 4Q

Expected Dividend Upto 2025 3Q

Expected Dividend Yield Upto 2025 3Q

Expected Dividend Growth Upto 2025 3Q

Dividend Cover Upto 2024 4Q

Payout Ratio Upto 2024 4Q

Expected Payout Ratio Upto 2025 3Q

Rs. 10.00

0.97 %

Rs. 13.67

1.33 %

36.70 %

5.35 x

18.71 %

Sales

Sales Per Share Upto 2024 4Q

Exp Sales Per Share Upto 2025 3Q

Price To Sales Upto 2024 4Q

Exp Price To Sales Upto 2025 3Q

Sales Per Share Growth Upto 2024 4Q

Exp Sales P/S Growth Upto 2025 3Q

Rs. 696.39

Rs. 765.77

1.47 x

1.34 x

22.90 %

9.96 %

Enterprise Value (EV)

EV To Sales Upto 2024 4Q

Exp EV To Sales Upto 2025 3Q

Enterprise Value Upto 2025 3Q

Market Capitalization Latest

EV To EBITDA Upto 2024 4Q

EV Per Share Upto 2025 3Q

1.42 x

1.25 x

Rs. 93.88 bn

Rs. 100.25 bn

8.74 x

Rs. 958.94

Cash

Cash Flow Per Share Upto 2025 3Q

Cash Per Share Upto 2025 3Q

Rs. 92.03

Profitablility

Net Profit Margin Upto 2024 4Q

Gross Profit Margin Upto 2024 4Q

EBIT Margin Upto 2024 4Q

EBITDA Margin Upto 2024 4Q

Net Interest Margin Upto 0

7.68 %

28.95 %

13.59 %

16.20 %

N/A %

Liquidity

Interest Cover Upto 2024 4Q

Times Interest Earned Upto 0

Inventory Turnover Upto 2024 4Q

Asset Turnover Upto 2024 4Q

Current Ratio Upto 2025 3Q

Effective Tax Rate Upto 2024 4Q

Quick Ratio Upto 2024 4Q

Net Interest To Assets Upto 2024 4Q

383.06 %

N/A %

6.37 %

181.08 %

2.16 x

41.98 %

1.08 x

52.42 %

Solvency

Long Debt To Equity

Total Debt To Equity

Long Debt To Assets Upto 2025 3Q

Total Debt To Assets Upto 2025 3Q

8.64 %

57.07 %

5.50 %

36.33 %